Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer

Published:2023-04 Issue: Volume:178 Page:66-74
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kang Jin^ORCID,Deng Qiu-Mei,Feng Weineng,Chen Zi-Hao,Su Jun-Wei^ORCID,Chen Hua-Jun,Wang Wen-xian,Zhang Shirong,Wang Qian,Chen Zexin,Zhong Wen-Zhao,Xu Chun-wei^ORCID,Yang Jin-Ji^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. CA Cancer;Siegel;J. Clin.,2021

2. MET-dependent solid tumours - Molecular diagnosis and targeted therapy;Guo;Nat. Rev. Clin. Oncol.,2020

3. G. Recondo, J. Che, P.A. Jänne, M.M. Awad, Targeting MET dysregulation in cancer, Cancer Discov. 10 (2020) 922–934. 10.1158/2159-8290.CD-19-1446.

4. E.Y. Rosen, M.L. Johnson, S.E. Clifford, R. Somwar, J.F. Kherani, J. Son, A.A. Bertram, M.A. Davare, E. Gladstone, E.V. Ivanova, D.N. Henry, E.M. Kelley, M. Lin, M.S.D. Milan, B.C. Nair, E.A. Olek, J.E. Scanlon, M. Vojnic, K. Ebata, J.F. Hechtman, B.T. Li, L.M. Sholl, B.S. Taylor, M. Ladanyi, P.A. Jänne, S.M. Rothenberg, A. Drilon, G.R. Oxnard, Overcoming MET-dependent resistance to selective RET inhibition in patients with RET fusion-positive lung cancer by combining selpercatinib with crizotinib, Clin. Cancer Res. 27 (2021) 34–42. 10.1158/1078-0432.CCR-20-2278.

5. I. Dagogo-Jack, S. Yoda, J.K. Lennerz, A. Langenbucher, J.J. Lin, M.M. Rooney, K. Prutisto-Chang, A. Oh, N.A. Adams, B.Y. Yeap, E. Chin, A. Do, H.D. Marble, S.E. Stevens, S.R. Digumarthy, A. Saxena, R.J. Nagy, C.H. Benes, C.G. Azzoli, M.S. Lawrence, J.F. Gainor, A.T. Shaw, A.N. Hata, MET alterations are a recurring and actionable resistance mechanism in ALK-positive lung cancer, Clin. Cancer Res. 26 (2020) 2535–2545. 10.1158/1078-0432.CCR-19-3906.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain;eLife;2024-09-13

2. Mutation of MET D1228N as an Acquired Potential Mechanism of Crizotinib Resistance in NSCLC with MET Y1003H Mutation;Lung Cancer: Targets and Therapy;2024-08

3. A telomere-related gene panel predicts the prognosis and Immune Status in gastric cancer;2024-07-18

4. Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer;The Oncologist;2024-07-02

5. Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain;2024-06-26